Skip to main content
. 2020 May 6;10:7662. doi: 10.1038/s41598-020-64713-x

Figure 4.

Figure 4

Interaction of AFAP1-AS1 with miR-145 and miR-145 with MTH1 in breast cancer cells. (A) qRT-PCR. MDA-MB-231 cells were transiently transfected with miR-145 mimics, negative control, ASO-miR-145, or ASO-NC for 48 h and subjected to qRT-PCR analysis of miR-145 expression. (B) Luciferase assay. MDA-MB-231 cells were transiently transfected with pmirGLO/AFAP1-AS1 3′-UTR, miR-145 mimics, negative control, ASO-miR-145, or ASO-NC for 48 h and subjected to Luciferase assay. The right panel shows the results of the Luciferase assay with mutated pmirGLO/AFAP1-AS1 3′-UTR transfection. (C) Luciferase assay. MDA-MB-231 cells were transiently transfected with pmirGLO/NUDT1 3′-UTR, miR-145 mimics, negative control, ASO-miR-145, or ASO-NC for 48 h and subjected to Luciferase assay. The right panel shows the results of the Luciferase assay with mutated pmirGLO/NUDT1 3′-UTR transfection. **p < 0.05 and ***p < 0.01.